This research service covers the U.S. rheumatoid arthritis (RA) market from 2007 to 2017, with 2010 as the base year. Included in this research service are products currently in the market, products in development, and patient forecasts. Market challenges, drivers, and restraints are identified and assessed. Strategic recommendations are presented to overcome listed industry challenges. This research service does not include market revenue forecasts for DMARDs. This research service highlights product forecasts for biologic products as well as small molecules near launch.

Table Of Contents

Table of Contents


Introduction to Hospital-acquired Infections10
Hospitals and Infections11
Hospital-acquired Infections: An Introduction12
Analysis Based on Wards13
Analysis Based on Intensive Care Unit14
Analysis Based on Other Issues15
Hospital-acquired Infections: Classification16-21
Causes of HAI 22
Types of Transmission Routes of HAI 23
Hospital-acquired Infections Australia 24
HAI -Overview 25
HAI -Global Scenario 26
HAI -Trends in Australia 27
Analysis Based on Type of Hospital-acquired Infections in Australia31
Blood Stream Infections 32
Surgical Site Infections 38
Respiratory Tract Infections 43
Urinary Tract Infections 48
Antimicrobial Resistance 53
Antimicrobial Resistance -Overview 54
Multi Resistant Organisms -Staphylococcus aureus (MRSA) 55
Multi Resistant Organisms -Enterrococci 57
Multi Resistant Organisms -Gram-negative Bacteria 58
Geographical Analysis 59
New South Wales 60
Victoria 63
Queensland 66
South Australia 69
Western Australia72
Hospital-acquired Infections -Qualitative Insights74
Conclusion 86
About Frost and Sullivan 89


List of Figures
Hospital-acquired Infections: Estimated Prevalence of HAI (World), 2009 26
Hospital-acquired Infections: Number of Hospitals (Australia), 2009 27
BloodStreamInfections:PredominantPathogensCausingBSI(World),2006-2009 35
BloodStreamInfections:PercentofCatheter-relatedBSIbyPathogen(Australia),2009 36
SurgicalSiteInfections:SpecimenTypeObtainedfromInfectionSites(Australia),2009 39
SurgicalSiteInfections:RiskofInfectionBasedonWoundTypes(Australia),2009 40
SurgicalSiteInfections:DistributionofPathogensIsolatedinSelectSurgicalProcedures(Australia),2009 41
RespiratoryTractInfections:ClassificationofCommonPathogensBasedontheOnsetofPneumonia(Australia),2009 45
UrinaryTractInfections:CommonPathogensthatCauseCatheter-relatedUTI(Australia),2009 51
AntimicrobialResistance:ListofAntibioticResistantPathogens(Australia),2009 54
Hospital-acquiredInfections:InitiativesforHAI(Australia),2009 78
Hospital-acquiredInfections:AnnualCasesofHAIbyStatesandType(Australia),2009 87
Hospital-acquiredInfections:EstimatedBedDaysLostduetoHAI(Australia),2009 87


List of Charts
Hospital-acquired Infections: Percent Split by Geographic Region (Australia), 2009 27
Hospital-acquired Infections: Percent Split by Infection Type (Australia), 2009 28
Bloodstream Infections: Percent Split of BSIs Based on Site of Infection (Australia), 2009 34
Blood Stream Infections: Patient Population by States and Territories (Australia), 2009 37
Surgical Site Infections: Incidence by Selected Surgical Procedures (Australia), 2009 41
Surgical Site Infections: Patient Population (Australia), 2009 42
Respiratory Tract Infections: Percent of Infection in ICUs by Infection Type (Australia), 2009 46
Respiratory Tract Infections: Patient Population (Australia), 2009 47
Urinary Tract Infections: Percent Split by Infection Type (Australia), 2009 50
Urinary Tract Infections: Percent of Risk of Infection by Pathogens (Australia), 2009 50
Urinary Tract Infections: Patient Population (Australia), 2009 52
Multi-ResistantOrganisms:ProportionofMRSAforallIsolates(Australia),2009 55
Hospital-acquired Infections: Annual Cases of HAIs (New South Wales), 2009 61
Hospital-acquired Infections: Annual Cases of HAIs (Victoria), 2009 64
Hospital-acquired Infections: Annual Cases of HAIs (Queensland), 2009 67
Hospital-acquired Infections: Annual Cases of HAIs (South Australia), 2009 70
Hospital-acquired Infections: Annual Cases of HAIs (Western Australia), 2009 73

View This Report »

Find all the market research you need - instantly, in one place.

+1.2 Million Research Documents & Statistics +200,000 Trusted Public Sources 350 Industries With Global Coverage

24/7 Customer Support

Talk to Amrita

+1 718 303 2019

Purchase Reports From Reputable Market Research Publishers

Analysis of the Global Infectious Disease Diagnostics Market

Analysis of the Global Infectious Disease Diagnostics Market

  • $ 10 000
  • Industry report
  • September 2014
  • by Frost & Sullivan

Molecular Methods Present Significant Opportunities This deliverable provides research and analysis of the global infectious disease diagnostics market. It includes an in-depth analysis of revenue forecast ...

OpportunityAnalyzer: Chronic Lymphocytic Leukemia - Opportunity Analysis and Forecasts to 2018

OpportunityAnalyzer: Chronic Lymphocytic Leukemia - Opportunity Analysis and Forecasts to 2018

  • $ 7 995
  • Industry report
  • June 2014
  • by Global Data

OpportunityAnalyzer: Chronic Lymphocytic Leukemia - Opportunity Analysis and Forecasts to 2018 Summary Chronic lymphocytic leukemia (CLL), the most common form of adult leukemia, is caused by the uncontrolled ...

Frontier Pharma: Breast Cancer - Identifying and Commercializing First-in-Class Innovation

Frontier Pharma: Breast Cancer - Identifying and Commercializing First-in-Class Innovation

  • $ 6 995
  • Industry report
  • July 2014
  • by GBI Research

Frontier Pharma: Breast Cancer - Identifying and Commercializing First-in-Class Innovation Summary Exceptionally Large and Innovative Pipeline The breast cancer pipeline is the largest in the pharmaceutical ...

Bcc Research Bitopertin Forecast

August 2014 $ 5 500

ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.